Literature DB >> 9712750

The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

M J Mathiesen1, A Holm, M Christiansen, J Blom, K Hansen, S Ostergaard, M Theisen.   

Abstract

Epitope mapping of outer surface protein C (OspC) by using sera from patients with neuroborreliosis led to the identification of one single major immunodominant epitope within the C-terminal 10 amino acid residues. Peptide binding studies and alanine replacement scanning of the C-terminal decapeptide, PVVAESPKKP, revealed a critical role for the PKKP sequence and its terminal carboxyl group for the binding of immunoglobulin M (IgM) antibodies from patients with Lyme borreliosis. Electron microscopy of antibody-labeled spirochetes indicated that the C-terminal region is exposed on the surface of the spirochete. Based on homology to proteins of known function, this region most probably adopts a polyproline II-like helix, which is found in surface-exposed structures involved in protein-protein interactions. This structural motif is highly conserved in Borrelia species causing Lyme borreliosis and subjected to purifying selection. We suggest that the abundance of the C-terminal region of OspC on the surface of B. burgdorferi allows a multimeric high-avidity interaction between the spirochete and surface Igs on B cells. The resulting cross-linking of surface Igs on B cells may induce a T-cell-independent B-cell activation without IgM-to-IgG switching, thus explaining the lack of IgG antibodies to OspC in neuroborreliosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712750      PMCID: PMC108488          DOI: 10.1128/IAI.66.9.4073-4079.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia.

Authors:  I Livey; C P Gibbs; R Schuster; F Dorner
Journal:  Mol Microbiol       Date:  1995-10       Impact factor: 3.501

2.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

Authors:  M Nei; T Gojobori
Journal:  Mol Biol Evol       Date:  1986-09       Impact factor: 16.240

Review 4.  The structure and function of proline-rich regions in proteins.

Authors:  M P Williamson
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.

Authors:  L K Bockenstedt; E Hodzic; S Feng; K W Bourrel; A de Silva; R R Montgomery; E Fikrig; J D Radolf; S W Barthold
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Analysis of the human antibody response to outer surface protein C (OspC) of Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii.

Authors:  M J Mathiesen; K Hansen; N Axelsen; L Halkier-Sørensen; M Theisen
Journal:  Med Microbiol Immunol       Date:  1996-11       Impact factor: 3.402

7.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

Authors:  B Wilske; V Fingerle; P Herzer; A Hofmann; G Lehnert; H Peters; H W Pfister; V Preac-Mursic; E Soutschek; K Weber
Journal:  Med Microbiol Immunol       Date:  1993-11       Impact factor: 3.402

9.  Immunochemical and immunological analysis of European Borrelia burgdorferi strains.

Authors:  B Wilske; V Preac-Mursic; G Schierz; K V Busch
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

10.  Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin.

Authors:  S Fuchs; E Mozes; A Maoz; M Sela
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  23 in total

1.  Multiple overlapping epitopes in the repetitive unit of the shed acute-phase antigen from Trypanosoma cruzi enhance its immunogenic properties.

Authors:  P Alvarez; M S Leguizamón; C A Buscaglia; T A Pitcovsky; O Campetella
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

3.  Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.

Authors:  Adam Norek; Lubomír Janda
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

4.  Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

Authors:  Christopher G Earnhart; Eric L Buckles; John Stephen Dumler; Richard T Marconi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.

Authors:  Jerilyn R Izac; Andrew C Camire; Christopher G Earnhart; Monica E Embers; Rebecca A Funk; Edward B Breitschwerdt; Richard T Marconi
Journal:  Vaccine       Date:  2019-03-25       Impact factor: 3.641

6.  Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis.

Authors:  J Panelius; P Lahdenne; H Saxen; T Heikkilä; I Seppälä
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.

Authors:  R D Gilmore; M L Mbow
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Authors:  Steven D Lovrich; Dean A Jobe; Ronald F Schell; Steven M Callister
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

9.  Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.

Authors:  Dean A Jobe; Todd J Kowalski; Marissa Bloemke; S D Lovrich; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

10.  Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.

Authors:  Dean A Jobe; Steven D Lovrich; Krista E Asp; Michelle A Mathiason; Stephanie E Albrecht; Ronald F Schell; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.